Vanguard Group Inc Dice Therapeutics, Inc. Transaction History

Vanguard Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $754,103 - $1.36 Million	29,161 Added 1.51%	1,957,417 $90.9 Million
Q1 2023 May 15, 2023	BUY	$26.05 - $32.31 $647,082 - $802,580	24,840 Added 1.31%	1,928,256 $55.2 Million
Q4 2022 Feb 10, 2023	BUY	$19.77 - $42.23 $10.2 Million - $21.8 Million	516,658 Added 37.26%	1,903,416 $59.4 Million
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $2.55 Million - $3.87 Million	170,649 Added 14.03%	1,386,758 $28.1 Million
Q2 2022 Aug 12, 2022	BUY	$13.19 - $22.1 $8.17 Million - $13.7 Million	619,476 Added 103.83%	1,216,109 $18.9 Million
Q1 2022 May 13, 2022	BUY	$14.54 - $25.02 $208,111 - $358,111	14,313 Added 2.46%	596,633 $11.4 Million
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $13 Million - $21.9 Million	582,320 New	582,320 $14.7 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.